30
Participants
Start Date
May 6, 2015
Primary Completion Date
November 16, 2018
Study Completion Date
December 17, 2018
Entospletinib
Vincristine
Dexamethasone
CNS Prophylaxis
Memorial Sloan-Kettering, New York
Medizinische Klinik mit Schwerpunkt Hepatologie & Gastroenterology, Berlin
Bon Secour St. Francis Hospital, Greenville
The Ohio State University, Columbus
University of Chicago, Chicago
UCLA, Los Angeles
City of Hope, Duarte
University of California San Diego (UCSD), San Diego
UC Irvine Medical Center, Orange
University of WA, Seattle
Hackensack University Medical Center, Hackensack
Princess Margaret, Toronto
Medizinische Klinik und Poliklinik I, Würzburg
Lead Sponsor
Gilead Sciences
INDUSTRY